|
14 Dec 2007 |
WILEX announces positive result of the interim analysis for futility of its Phase III ARISER trial with RENCAREX(R)
|
|
13 Dec 2007 |
Merck Announces Initiation of Phase II/III Clinical Trial of Atacicept in Lupus Nephritis
|
|
13 Dec 2007 |
Genmab announces details of planned Ofatumumab Phase II study in multiple sclerosis
|
|
13 Dec 2007 |
Genmab initiates Ofatumumab Phase II study in diffuse large b-cell lymphoma
|
|
11 Dec 2007 |
ThromboGenics Presents Results of the Phase I Trial of TB-402 at thePrestigious American Society of Hematology Annual Meeting
|
|
11 Dec 2007 |
Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
|
|
11 Dec 2007 |
Seattle Genetics Reports Multiple Complete Remissions With SGN-33 in Acute Myeloid Leukemia at ASH
|
|
11 Dec 2007 |
GlaxoSmithKline and OncoMed Pharmaceuticals Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics
|
|
10 Dec 2007 |
Genitope Corporation Presents New Data On Its Therapeutic Monoclonal Antibodies To Potentially Treat B-Cell Malignancies
|
|
10 Dec 2007 |
MorphoSys Broadens Scope of Collaboration with GeneFrontier
|
|
10 Dec 2007 |
PDL BioPharma Presents Data on Novel Monoclonal Antibody for Multiple Myeloma at the 2007 American Society of Hematology Annual Meeting
|
|
10 Dec 2007 |
Ablynx announces extension of Nanobody (R) drug discovery and development alliance
|
|
10 Dec 2007 |
Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
|
|
10 Dec 2007 |
Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkin's Lymphoma
|
|
10 Dec 2007 |
Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
|
|
10 Dec 2007 |
Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML)
|
|
10 Dec 2007 |
Biolex Researchers Present Results of Anti-CD20 Antibody With Optimized Glycosylation at ASH Conference
|
|
09 Dec 2007 |
ImmunoGen, Inc. Announces Encouraging Clinical Findings Reported at ASH Annual Meeting for TAP Compound AVE9633
|
|
08 Dec 2007 |
ImmunoGen, Inc. Announces Encouraging Clinical Findings Reported at ASH Annual Meeting with Targeted Anticancer Compounds IMGN901 (HuN901-DM1) and AVE1642
|
|
07 Dec 2007 |
Genmab's HuMax-CD38 Enters Phase I/II Clinical Trial For Multiple Myeloma
|
|
07 Dec 2007 |
Seattle Genetics Initiates SGN-40 Phase IIb Clinical Trial in Combination with Rituxan and Chemotherapy for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
|
|
06 Dec 2007 |
Raven biotechnologies, Inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
|
|
05 Dec 2007 |
Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
|
|
05 Dec 2007 |
BioInvent Designates Drug Candidate, BI-505, for the Treatment of Cancer
|
|
05 Dec 2007 |
Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
|
